Novel CRISPR-Cas Enzyme Variants and Methods of Use

Tech ID: 32296 / UC Case 2021-113-0

Patent Status

Country Type Number Dated Case
Patent Cooperation Treaty Published Application WO 2023/039373 03/16/2023 2021-113

Brief Description

CRISPR-Cas systems include Cas proteins, which are involved in acquisition, targeting and cleavage of foreign DNA or RNA, and a guide RNA(s), which includes a segment that binds Cas proteins and a segment that binds to a target nucleic acid. For example, Class 2 CRISPR-Cas systems comprise a single Cas protein bound to a guide RNA, where the Cas protein binds to and cleaves a targeted nucleic acid. The programmable nature of these systems has facilitated their use as a versatile technology for use in modification of target nucleic acid.


UC Berkeley researchers have discovered novel CRISPR-Cas proteins related to other CRISPR-Cas systems that utilize a single guide RNA (sgRNA) or a combination of a tracrRNA + guide RNA to perform RNA-directed cleavage of nucleic acids that can be applicable for DNA editing and diagnostics. The enzyme can cleave the target DNA and may be used for diagnostics by utilizing its ability to cleave single-stranded DNA in trans.


Suggested uses

  • gene editing of bacterial, archaeal, and eukaryotic cells
  • transcription repression of specific genes

Learn About UC TechAlerts - Save Searches and receive new technology matches

Other Information


CRISPR, gene editing

Categorized As